VIR stock Statistics — Vir Biotechnology, Inc. filings, insiders & smart money

Price and daily changeSign in

Earnings4 Nov 2026

52-week rangeSign inDay rangeSign in

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstandingAs of 2026-07-29 · filed common shares: 169.21M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.02%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 12.61%
Short ratioDays to cover, as published by FINRA: 11.10
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 65.30%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 59.30%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Gross marginTTM to Jun 26: 100.00%
Operating marginTTM to Jun 26: -92.40%
Net margin: —
EBITDA marginTTM to Jun 26: -88.61%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -26.08%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -20.91%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

-1.77

EPS (fwd)

Cash & equivalentsas of Jun 26: $278.72M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $93.27M
Debt / equityas of Jun 26: 9.49%
Current ratioas of Jun 26: 6.04
Quick ratio: —
Operating cash flowTTM to Jun 26: -$202.50M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$203.59M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 2.04